Cell Press

SHERPA: Unknown

People

  1. Levine
    Levine
  2. Schultz
    Schultz
  3. Sawyers
    Sawyers
  4. Solit
    Solit
  5. Ladanyi
    Ladanyi
  6. Abdel-Wahab
    Abdel-Wahab
  7. Chandarlapaty
    Chandarlapaty
  8. De Stanchina
    De Stanchina
  9. Rudin
    Rudin
  10. Berger
    Berger

Groups

  1. Human Oncology and Pathogenesis Program (242)
  2. GSK Faculty (237)
  3. Department of Medicine (182)
  4. Sloan Kettering Institute Postdocs (127)
  5. Center for Hematologic Malignancies (106)
  6. Hematologic Malignancies, Division of (106)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (86)
  8. Solid Tumor Oncology Division (83)
  9. Tow Center for Developmental Oncology (TCDO) (83)
  10. Department of Pathology and Laboratory Medicine (81)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (203)
  2. Editorial (23)
  3. Meeting Abstract (9)
  4. Review (5)
  5. Miscellaneous (1)
  6. Research Letter (1)
Groups
  1. Human Oncology and Pathogenesis Program (242)
  2. GSK Faculty (237)
  3. Department of Medicine (182)
  4. Sloan Kettering Institute Postdocs (127)
  5. Center for Hematologic Malignancies (106)
  6. Hematologic Malignancies, Division of (106)

More Groups

People
  1. Ross Levine (47)
  2. Nikolaus Schultz (29)
  3. Charles Sawyers (21)
  4. David Solit (20)
  5. Marc Ladanyi (19)
  6. Omar Abdel-Wahab (16)

More People

Years
  1. 2025 (7)
  2. 2024 (20)
  3. 2023 (14)
  4. 2022 (20)
  5. 2021 (24)
  6. 2020 (16)

More Years

Publications
  1. Cancer Cell (95)
  2. Cell Reports (36)
  3. Cell (32)
  4. Immunity (15)
  5. Cell Host & Microbe (11)
  6. Molecular Cell (10)

More Publications

Results (242)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated genomic characterization of papillary thyroid carcinoma
    Journal Article

    The Cancer Genome Atlas Research Network
    Cell (2014)

    Fulltext@MSK | Save
  • Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion
    Journal Article

    Zhang, J.; Fan, J.; Venneti, S.; Cross, J. R.; Takagi, T.; Bhinder, B.; Djaballah, H.; Kanai, M.; Cheng, E. H.; Judkins, A. R.; more...
    Molecular Cell (2014)

    Fulltext@MSK | Save
  • Combination of RAF and MEK inhibition for the treatment of BRAF-mutated melanoma: Feedback is not encouraged
    Journal Article

    Chapman, P. B.; Solit, D. B.; Rosen, N.
    Cancer Cell (2014)

    Fulltext@MSK | Save
  • DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia
    Journal Article

    Rampal, R.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J.; Li, Y.; Ahn, J.; Abdel-Wahab, O.; Shih, A.; more...
    Cell Reports (2014)

    Fulltext@MSK | Save
  • The somatic genomic landscape of chromophobe renal cell carcinoma
    Journal Article

    Davis, C. F.; Ricketts, C. J.; Wang, M.; Yang, L.; Cherniack, A. D.; Shen, H.; Buhay, C.; Kang, H.; Kim, S. C.; Fahey, C. C.; more...
    Cancer Cell (2014)

    Fulltext@MSK | Save
  • Identification of multipotent luminal progenitor cells in human prostate organoid cultures
    Journal Article

    Karthaus, W. R.; Iaquinta, P. J.; Drost, J.; Gracanin, A.; Van Boxtel, R.; Wongvipat, J.; Dowling, C. M.; Gao, D.; Begthel, H.; Sachs, N.; more...
    Cell (2014)

    Fulltext@MSK | Save
  • Organoid cultures derived from patients with advanced prostate cancer
    Journal Article

    Gao, D.; Vela, I.; Sboner, A.; Iaquinta, P. J.; Karthaus, W. R.; Gopalan, A.; Dowling, C.; Wanjala, J. N.; Undvall, E. A.; Arora, V. K.; more...
    Cell (2014)

    Fulltext@MSK | Save
  • Merlin/NF2 loss-driven tumorigenesis linked to CRL4DCAF1-mediated inhibition of the hippo pathway kinases lats1 and 2 in the nucleus
    Journal Article

    Li, W.; Cooper, J.; Zhou, L.; Yang, C.; Erdjument-Bromage, H.; Zagzag, D.; Snuderl, M.; Ladanyi, M.; Hanemann, C.; Zhou, P.; more...
    Cancer Cell (2014)

    Fulltext@MSK | Save
  • Disruption of CRAF-Mediated MEK activation is required for effective mek inhibition in KRAS mutant tumors
    Journal Article

    Lito, P.; Saborowski, A.; Yue, J.; Solomon, M.; Joseph, E.; Gadal, S.; Saborowski, M.; Kastenhuber, E.; Fellmann, C.; Ohara, K.; more...
    Cancer Cell (2014)

    Fulltext@MSK | Save
  • MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia
    Journal Article

    Chen, C.; Liu, Y.; Rappaport, A. R.; Kitzing, T.; Schultz, N.; Zhao, Z.; Shroff, A. S.; Dickins, R. A.; Vakoc, C. R.; Bradner, J. E.; more...
    Cancer Cell (2014)

    Fulltext@MSK | Save

    • Cell Press – authorized name for: